Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: Relevance to peripheral myeloid recruitment

European Journal of Immunology

Volumn 32, Issue 7, 2002, Pages 1897-1904

  Leite de Moraes, Maria C ^a,b   Lisbonne, Mariette ^a   Arnould, Anne ^a   Machavoine, François ^a   Herbelin, André ^b   Dy, Michel ^a   Schneider, Elke ^a,b  

^a CNRS   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

galactosylceramide; CD1d; Colony forming unit cell; Neutrophil; NKT lymphocyte

Indexed keywords

CYTOKINE; GALACTOSYLCERAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; LIGAND; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL MOTILITY; COLONY FORMING UNIT C; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOCYTE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; GALACTOSYLCERAMIDES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIESIS, EXTRAMEDULLARY; INJECTIONS; INTERFERON TYPE II; INTERLEUKIN-3; INTERLEUKIN-4; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; T-LYMPHOCYTES;

EID: 0036319459     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200207)32:7<1897::AID-IMMU1897>3.0.CO;2-Y     Document Type: Article

References (39)

1. NKT cells: Facts, functions and fallacies
2. Mouse CD1-specific NK1 T cells: Development, specificity, and function
3. - T cells in mice and humans
4. Impaired NK1 T cell development and early IL-4 production in CD1-deficient mice
5. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
6. + T cells are a potential source of IL-4 during primary immune response
7. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement
8. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells
9. Activation of natural killer T cells by a-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes
10. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
11. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors
12. CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi
13. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
14. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria
15. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
16. - NKT cells with distinct TCR alpha beta repertoires and differential distribution in lymphoid tissues
17. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
18. + NK T lymphocytes
19. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules and auto-presents the α-galactosylceramide antigen
20. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
21. Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host disease
22. In vitro and in vivo histamine-producing cell-stimulating factor (or IL-3) production during Nippostrongylus brasiliensis infection: Coincidence with self-cure phenomenon
23. Heterogeneity of NK1.1+ T cells in the bone marrow: Divergence from the thymus
24. Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes
25. In vivo effect of murine recombinant interleukin 3 on early hematopoietic progenitors
26. Hemopoietic regulators: Redundancy or subtlety?
27. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice
28. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection
29. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice
30. Role for interleukin-3 in masT cell and basophil development and in immunity to parasites
31. The natural killer T cell ligand a-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
32. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 biais of natural killer T cells
33. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis
34. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells
35. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo
36. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice
37. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-Ipr/Ipr mice
38. Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: Involvement of tumor necrosis factor-α
39. IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells